IP Library › Granted Patent US 12,235,264
Granted Patent B2
US 12,235,264 · App. 17/058,108 · Granted Feb 25, 2025

Enhanced cytometry for tissue characterization and screening

Inventors: Nallakkan Arvindan (Moraga, CA); Stephen Mehi (San Francisco, CA); Guanqing Ou (South San Francisco, CA)
Assignee: FIVE PRIME THERAPEUTICS, INC.
G01N33/54366B01F23/50G02B13/22G02B15/00G02B21/0088G02B21/16G02B21/26B01J2219/00351B01J2219/00418
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,235,264
App. No.
17/058,108
Granted
Feb 25, 2025
Kind
B2
Abstract

An optical imaging system ( 100 ) includes a frame ( 102 ) designed to provide mechanical coupling between a first stage ( 104 ) and a second stage ( 106 ), a sample holding region ( 108 ) located on the first stage ( 104 ), a lens arrangement, and a sensor array. The lens arrangement is disposed between the first stage ( 104 ) and the second stage ( 106 ) and is designed to receive light from a sample at the sample holding region ( 108 ) on the first stage. The lens arrangement has a numerical aperture less than 0.1. The sensor array is coupled to the second stage ( 106 ) and is designed to receive light passing through the lens arrangement.

Claims (29)

1. An optical imaging system, comprising:

a first stage comprising a sample holding region;

a frame configured to provide mechanical coupling between the first stage and a second stage,

wherein the first stage is configured to support a substrate comprising a plurality of microfluidic channels such that, in operation, the sample holding region holding a sample is located below the substrate supported by the first stage and a solution comprising fluorescently tagged probe molecules contacts the sample as the solution flows through the plurality of microfluidic channels;

one or more lenses disposed between the first stage and the second stage, the one or more lenses configured to receive light from the sample at the first stage, wherein an arrangement of the one or more lenses has a numerical aperture less than 0.1; and

a sensor array coupled to the second stage and configured to receive light passing through the one or more lenses, wherein the sensor array is configured to receive light passing through the one or more lenses to detect light fluorescing from the fluorescently tagged probe molecules.

2. The optical imaging system of claim 1 , wherein the one or more lenses comprises a telecentric lens.

3. The optical imaging system of claim 1 , further comprising a housing coupled to the second stage and configured to house the one or more lenses.

4. The optical imaging system of claim 3 , wherein the housing further comprises one or more of a bandpass filter, a longpass filter, or a polarization filter.

5. The optical imaging system of claim 3 , wherein the housing includes an opening along a side of the housing such that light received at the opening is directed towards the sample holding region.

6. The optical imaging system of claim 5 , wherein the housing includes an angled filter configured to reflect the light received at the opening and pass the light received from the sample.

7. The optical imaging system of claim 1 , wherein the one or more lenses comprises a plurality of lenses.

8. The optical imaging system of claim 1 , wherein the sensor array comprises a complementary metal oxide semiconductor (CMOS) sensor array.

9. The optical imaging system of claim 1 , further comprising a light source configured to provide excitation light towards the sample holding region.

10. The optical imaging system of claim 1 , wherein the first stage includes one or more of a bandpass filter, a longpass filter, or a polarization filter disposed beneath the first stage sample holding region.

11. A method of capturing fluorescent images of a sample using the optical imaging system of claim 1 , comprising:

disposing the sample over the sample holding region;

disposing the substrate over the sample;

flowing the solution through the plurality of microfluidic channels such that the solution contacts the sample;

receiving the light fluorescing from the fluorescently tagged probe molecules bound to the sample using the one or more lenses; and

detecting the light fluorescing from the fluorescently tagged probe molecules at the sensor array.

12. The method of claim 11 , further comprising disposing a prism block over the substrate.

13. The method of claim 12 , further comprising directing excitation light through the prism block towards the sample holding region.

14. The method of claim 11 , wherein the flowing comprises flowing the solution at a substantially constant flow rate through the plurality of microfluidic channels.

15. The method of claim 11 , wherein the detecting comprises detecting the light fluorescing from the fluorescently tagged probe molecules at a CMOS sensor array.

16. The method of claim 11 , further comprising filtering light received by the one or more lenses using at least one of a bandpass filter, longpass filter, or polarization filter.

17. The method of claim 11 , wherein the flowing comprises flowing the solution via an applied pressure.

18. The method of claim 11 , wherein the lens arrangement comprises a telecentric lens.

19. The method of claim 11 , further comprising directing excitation light through the one or more lenses towards the sample holding region.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2025
From: ARVINDAN, NALLAKKAN; MEHI, STEPHEN; OU, GUANQING
To: FIVE PRIME THERAPEUTICS, INC.
Reel/Frame 069909/0853 →
Continuity (2)
Provisional Application 62676620 · May 25, 2018
Related Publication 20210215687A1 · Jul 15, 2021
References Cited (37)
US 10168525B2 · Kim et al. · 2019 [cited by applicant]
US 20020159162A1 · Ramm · 2002 [cited by examiner]
US 20030151735A1 · Blumenfeld · 2003 [cited by examiner]
US 20100019157A1 · Furlan · 2010 [cited by examiner]
US 20150323462A1 · Ghosh et al. · 2015 [cited by applicant]
US 20160216503A1 · Kim · 2016 [cited by examiner]
EP 2148187A1 · 2010 [cited by applicant]
JP 2008224465A · 2008 [cited by applicant]
JP 2009015047A · 2009 [cited by applicant]
JP 2010032513A · 2010 [cited by applicant]
JP 2013150567A · 2013 [cited by applicant]
JP 2017049069A · 2017 [cited by applicant]
JP 2018504628A · 2018 [cited by applicant]
Chinese Patent Application No. 201980030877.6, Office Action and Search Report, dated May 25, 2023. [cited by applicant]
Wittig et al., A reusable microfluidic plate with alternate-choice architecture for assessing growth preference in tissue culture, J. Neurosci. Methods, 144(1):79-89 (2005). [cited by applicant]
Ciftlik et al., Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and signficantly reudces ambiguous (2+) read-outs, Proc. Natl. Acad. Sci., 110(14):5363-8 (2013). [cited by applicant]
European Patent Application No. 19730072, Examination Report, dated Jun. 6, 2023. [cited by applicant]
Written Opinion and International Search Report from International Application No. PCT/US2019/033755, dated Nov. 29, 2019, 20 pages. [cited by applicant]
Japanese Patent Application No. 2020-563650, Notice of Reasons for Refusal, mailed Feb. 22, 2023. [cited by applicant]
Boute, N., et al., “NanoLuc Luciferase—A Multifunctional Tool for High Throughput Antibody Screening,” [cited by applicant]
“ChipCytometry,” Canopy Biosciences website, accessed Sep. 3, 2021, at https://info.canopybiosciences.com/chip-cytometry; 9 pages. [cited by applicant]
“Centrifuge-Free Next-Generation Cell Washing,” Curiox Bio Systems website, accessed Sep. 3, 2021 at http://www.curiox.com; 7 pages. [cited by applicant]
“X-Cite mini+ Compact, LED Illumination System,” Excelitas Technologies Corp. website, accessed Sep. 3, 2021 at https://www.excelitas.com/product/x-cite-mini-compact-led-illumination-system; 2 pages. [cited by applicant]
“The Maxpar Direct Immune Profiling System,” Fluidigm Corporation flyer, 2019, downloaded Sep. 3, 2021 at https://www.fluidigm.com/singlearticles/maxpar-direct-immune-profiling-assay; 4 pages. [cited by applicant]
“Multiplexed Tissue Imaging Platform,” GE Research website, accessed Sep. 3, 2021 at https://www.ge.com/research/project/multiplexed-tissue-imaging-platform; 2 pages. [cited by applicant]
Giesen, C., et al., “Highly multiplexed imaging of tumortissues with subcellular resolution by mass cytometry,” [cited by applicant]
“ImagEM X2 EM-CCD camera C9100-23B,” Hamamatsu Photonics K.K. website, accessed Sep. 3, 2021 at https://www.hamamatsu.com/us/en/product/type/C9100-23B/index.html; 6 pages. [cited by applicant]
“NIST Traceable Luminometer Reference Microplate,” Harta Instruments website, accessed Sep. 3, 2021 at http://www.hartainstruments.com/refplate.html; 1 page. [cited by applicant]
“On-chip Sort,” On-chip Biotechnologies Co., Ltd. Corporation website, accessed Sep. 3, 2021 at https://on-chipbio.com/; 11 pages. [cited by applicant]
“Microfluidic Cell Sorter: On-chip Sort,” On-chip Biotechnologies Co., Ltd. Corporation website, accessed Sep. 3, 2021 at https://on-chipbio.com/product-onchip_sort/; 8 pages. [cited by applicant]
“LV200 Bioluminescence Imaging System: Overview,” Olympus Corporation website, accessed Sep. 3, 2021 at https://www.olympus-lifescience.com/en/microscopes/inverted/lv200/; 6 pages. [cited by applicant]
“LV200 Bioluminescence Imaging System: Specifications,” Olympus Corporation website, accessed Sep. 3, 2021 at https://www.olympus-lifescience.com/en/microscopes/inverted/lv200/; 2 pages. [cited by applicant]
“On-chip Sort,” PHC Corporation website, accessed Sep. 3, 2021 at https://www.phchd.com/global/biomedical/on-chip-sort; 7 pages. [cited by applicant]
Riching, K., et al., “Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling ofPROTAC Mode of Action,” [cited by applicant]
Moreira, N.M., et al., “Imaging strategies for bio inspired materials,” [cited by applicant]
Gu, Biomedical engineering planning textbook of national ordinary institutes of higher learning, Biomedical Engineering Technology, Beijing: Chinese Medical Science and Technology Press (Jul. 2017). [cited by applicant]
Chinese Application No. 20198003087.6, Rejection Decision, dated Aug. 30, 2024. [cited by applicant]